|Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues|
K Yuan, N Frolova, Y Xie, D Wang, L Cook, YJ Kwon, AD Steg, R Serra, ...
Journal of Histochemistry & Cytochemistry 58 (10), 857-870, 2010
|Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV‐40 tag rats|
CE Harper, LM Cook, BB Patel, J Wang, IA Eltoum, A Arabshahi, T Shirai, ...
The Prostate 69 (15), 1668-1682, 2009
|Metastasis suppressors and the tumor microenvironment|
LM Cook, DR Hurst, DR Welch
Seminars in cancer biology 21 (2), 113-122, 2011
|An Integrated Computational Model of the Bone Microenvironment in Bone-Metastatic Prostate Cancer|
A Araujo, LM Cook, CC Lynch, D Basanta
Cancer research 74 (9), 2391-2401, 2014
|Integrating new discoveries into the “vicious cycle” paradigm of prostate to bone metastases|
LM Cook, G Shay, A Aruajo, CC Lynch
Cancer and Metastasis Reviews 33 (2-3), 511-525, 2014
|Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition|
TM Bodenstine, KS Vaidya, A Ismail, BH Beck, LM Cook, AR Diers, ...
Cancer research 70 (23), 10002-10011, 2010
|Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer|
LM Cook, A Araujo, JM Pow-Sang, MM Budzevich, D Basanta, CC Lynch
Scientific Reports 6, 2016
|Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling|
J Gallaher, LM Cook, S Gupta, A Araujo, J Dhillon, JY Park, JG Scott, ...
Clinical & experimental metastasis 31 (8), 991-999, 2014
|Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival|
S Khadge, GM Thiele, JG Sharp, TR McGuire, LW Klassen, PN Black, ...
Clinical & experimental metastasis 35 (8), 797-818, 2018
|Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis|
LM Cook, X Cao, AE Dowell, MT Debies, MD Edmonds, BH Beck, ...
Clinical & experimental metastasis 29 (4), 315-325, 2012
|The Proteomic Landscape of Pancreatic Ductal Adenocarcinoma Liver Metastases Identifies Molecular Subtypes and Associations with Clinical Response|
HCH Law, D Lagundžin, EJ Clement, F Qiao, ZS Wagner, KL Krieger, ...
Clinical Cancer Research, 2019
|Pre-osteoblastic MC3T3-E1 cells promote breast cancer growth in bone in a murine xenograft model|
TM Bodenstine, BH Beck, X Cao, LM Cook, A Ismail, JK Powers, ...
Chinese journal of cancer 30 (3), 189, 2011
|Unmasking the Many Faces of Tumor-Associated Neutrophils and Macrophages: Considerations for Targeting Innate Immune Cells in Cancer|
T Keeley, DL Costanzo-Garvey, LM Cook
Trends in Cancer, 2019
|Immune regulation and anti-cancer activity by lipid inflammatory mediators|
S Khadge, JG Sharp, TR McGuire, GM Thiele, P Black, C DiRusso, ...
International immunopharmacology 65, 580-592, 2018
|Characterization of SV-40 Tag rats as a model to study prostate cancer|
CE Harper, BB Patel, LM Cook, J Wang, T Shirai, IA Eltoum, ...
BMC cancer 9 (1), 1, 2009
|Neutrophils are mediators of metastatic prostate cancer progression in bone|
DL Costanzo-Garvey, T Keeley, AJ Case, GF Watson, M Alsamraae, Y Yu, ...
Cancer Immunology, Immunotherapy, 1-18, 2020
|Size Matters: Metastatic cluster size and stromal recruitment in the establishment of successful prostate cancer to bone metastases|
A Araujo, LM Cook, CC Lynch, D Basanta
Bulletin of mathematical biology 80 (5), 1046-1058, 2018
|Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis|
LM Cook, JS Frieling, N Nerlakanti, JJ McGuire, PA Stewart, KL Burger, ...
Oncogene, 1-11, 2019
|Roles for matrix metalloproteinase-3 (MMP-3) in the prostate tumor-bone microenvironment.|
JS Frieling, LA Pamen, LM Cook, S Yang, CC Lynch
Cancer Research 73 (8 Supplement), 5061-5061, 2013
|Mesenchymal stem cells promote osteogenesis and the evolution of apoptosis resistant bone metastatic prostate cancer|
JJ McGuire, L Cook, J Frieling, C Lynch
Cancer Research 75 (15 Supplement), 5072-5072, 2015